Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$7,205
New position
Shares Held
38
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,394
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARYLAND CAPITAL ADVISORS INC. holds $1,214,787 across 12 Drug Manufacturers - General names. AZN ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,448 | $367,747 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,577 | $331,144 | |
| 3 | AMGN |
Amgen Inc
|
698 | $252,759 | |
| 4 | ABBV |
AbbVie Inc.
|
963 | $242,329 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
38 | $7,205 | |
| 6 | NVS |
Novartis AG
|
39 | $6,112 | |
| 7 | OGN |
Organon & Co.
|
253 | $3,425 | |
| 8 | LLY |
ELI LILLY & Co
|
2 | $2,398 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,205 | 38 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||